Merck and Moderna Secure Clinical Breakthrough for mRNA Cancer Therapy

By Adam Feuerstein · STAT News · 2026-08-20

STAT News reports that recent late-stage clinical trial data for a personalized mRNA melanoma therapy has marked a significant milestone for the biotechnology sector. This development follows a separate success for a KRAS-targeted drug from Revolution Medicines, signaling a major

STAT News reports that recent late-stage clinical trial data for a personalized mRNA melanoma therapy has marked a significant milestone for the biotechnology sector. This development follows a separate success for a KRAS-targeted drug from Revolution Medicines, signaling a major